{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:55:53Z","timestamp":1790646953982,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13770-026-00830-4","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:15:01Z","timestamp":1786720501000},"page":"989-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical and Clinical Translation of Immunomodulatory Role of Mesenchymal Stem Cells in Cancer Therapy Era"],"prefix":"10.1007","volume":"23","author":[{"given":"Yutao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2021.11.015","volume":"526","author":"F Zhang","year":"2022","unstructured":"Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, et al. Mesenchymal stem cell-derived exosome: a tumor regulator and carrier for targeted tumor therapy. Cancer Lett. 2022;526:29\u201340.","journal-title":"Cancer Lett"},{"key":"830_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114551","volume":"43","author":"L Frisbie","year":"2024","unstructured":"Frisbie L, Pressimone C, Dyer E, Baruwal R, Garcia G, St Croix C, et al. Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer. Cell Rep. 2024;43:114551.","journal-title":"Cell Rep"},{"key":"830_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21:179.","journal-title":"Mol Cancer"},{"key":"830_CR4","doi-asserted-by":"publisher","DOI":"10.36922\/bh.2065","volume":"2","author":"MS Poomani","year":"2024","unstructured":"Poomani MS, Radhakrishnan V, James SB, Muthan K, Subramanian V. Therapeutic potential of mesenchymal stem cells and their mechanisms of regeneration for cardiac diseases. Brain Heart. 2024;2:2065.","journal-title":"Brain Heart"},{"key":"830_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cytogfr.2024.03.002","volume":"77","author":"U \u0160vajger","year":"2024","unstructured":"\u0160vajger U, Kamen\u0161ek U. Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer. Cytokine Growth Factor Rev. 2024;77:76\u201390.","journal-title":"Cytokine Growth Factor Rev"},{"key":"830_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2025.102327","volume":"92","author":"S Fu","year":"2025","unstructured":"Fu S, Yeung CK, Xu RH. Pluripotent stem cell-derived mesenchymal stem cells for therapeutic applications, developmental study, and cancer research. Curr Opin Genet Dev. 2025;92:102327.","journal-title":"Curr Opin Genet Dev"},{"key":"830_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102215","volume":"34","author":"P Shen","year":"2025","unstructured":"Shen P, Huang K, Zhang X, Yin G, Qin M, Ma H, et al. Genetically engineered MSC-derived hybrid cellular vesicles for ROS-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury. Mater Today Bio. 2025;34:102215.","journal-title":"Mater Today Bio"},{"key":"830_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112171","volume":"134","author":"F Lavi Arab","year":"2024","unstructured":"Lavi Arab F, Hoseinzadeh A, Hafezi F, Sadat Mohammadi F, Zeynali F, Hadad Tehran M, et al. Mesenchymal stem cell-derived exosomes for management of prostate cancer: an updated view. Int Immunopharmacol. 2024;134:112171.","journal-title":"Int Immunopharmacol"},{"key":"830_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2022.102864","volume":"63","author":"M Rahimi Tesiye","year":"2022","unstructured":"Rahimi Tesiye M, Abrishami Kia Z, Rajabi-Maham H. Mesenchymal stem cells and prostate cancer: a concise review of therapeutic potentials and biological aspects. Stem Cell Res. 2022;63:102864.","journal-title":"Stem Cell Res"},{"key":"830_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semcancer.2022.09.002","volume":"86","author":"Z Tu","year":"2022","unstructured":"Tu Z, Karnoub AE. Mesenchymal stem\/stromal cells in breast cancer development and management. Semin Cancer Biol. 2022;86:81\u201392.","journal-title":"Semin Cancer Biol"},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"e164216","DOI":"10.1172\/jci.insight.164216","volume":"8","author":"G Augimeri","year":"2023","unstructured":"Augimeri G, Gonzalez ME, Paol\u00ec A, Eido A, Choi Y, Burman B, et al. A hybrid breast cancer\/mesenchymal stem cell population enhances chemoresistance and metastasis. JCI Insight. 2023;8:e164216.","journal-title":"JCI Insight"},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.2174\/0109298673309489240816063313","volume":"32","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Wang L, Zhang S, Jian W, Zeng B, Liang L, et al. The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cells lines. Curr Med Chem. 2025;32:7314\u201326.","journal-title":"Curr Med Chem"},{"key":"830_CR13","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1039\/C9RA00834A","volume":"9","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yang C, Mao J, Li H, Ding J, Zhou W. Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy. RSC Adv. 2019;9:11026\u201337.","journal-title":"RSC Adv"},{"key":"830_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5114\/ceji.2021.111753","volume":"46","author":"F Han","year":"2021","unstructured":"Han F, Guo S, Huang C, Cui L, Zhao Y, Ma J, et al. Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1. Cent Eur J Immunol. 2021;46:427\u201337.","journal-title":"Cent Eur J Immunol"},{"key":"830_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13062-024-00479-w","volume":"19","author":"X Gao","year":"2024","unstructured":"Gao X, Ren H, Zhang Z, Cao S, Zhang B, Sun Q, et al. Human lung cancer-derived mesenchymal stem cells promote tumor growth and immunosuppression. Biol Direct. 2024;19:39.","journal-title":"Biol Direct"},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"963689722110445","DOI":"10.1177\/09636897221104452","volume":"31","author":"KH Wang","year":"2022","unstructured":"Wang KH, Chang YH, Harnod T, Ding DC. Endometrial cancer-infiltrating mesenchymal stem cells exhibit immunosuppressive effects. Cell Transplant. 2022;31:9636897221104452.","journal-title":"Cell Transplant"},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2147\/JIR.S499403","volume":"18","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen W, Zhou J, Liang Q, Zhang Y, Su M, et al. The benefits and safety of monoclonal antibodies: implications for cancer immunotherapy. J Inflamm Res. 2025;18:4335\u201357.","journal-title":"J Inflamm Res"},{"key":"830_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101375","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang H, Feng Y, Xie X, Song T, Yang G, Su Q, et al. Engineered mesenchymal stem cells as a biotherapy platform for targeted photodynamic immunotherapy of breast cancer. Adv Healthc Mater. 2022;11:e2101375.","journal-title":"Adv Healthc Mater"},{"key":"830_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2023.102247","volume":"85","author":"R Khamooshi","year":"2023","unstructured":"Khamooshi R, Salimi A, Halabian R, Saeedi P. Apoptotic effects of mesenchymal stem cells\u2019 conditioned medium on colorectal cancer cell lines. Tissue Cell. 2023;85:102247.","journal-title":"Tissue Cell"},{"key":"830_CR20","doi-asserted-by":"publisher","first-page":"1751463","DOI":"10.3389\/fimmu.2026.1751463","volume":"17","author":"S Dong","year":"2026","unstructured":"Dong S, Liu Z, Wang Z, Peng X, Huang Q, Yang H, et al. Experimental study on synergistic pulses improving the tumor microenvironment and assisting immunotherapy. Front Immunol. 2026;17:1751463. .","journal-title":"Front Immunol"},{"key":"830_CR21","doi-asserted-by":"publisher","first-page":"1383255","DOI":"10.3389\/fimmu.2024.1383255","volume":"15","author":"L Huang","year":"2024","unstructured":"Huang L, Tan J, Lin P, Chen Z, Huang Q, Yao H, et al. Autoimmune encephalitis followed by hemophagocytic lymph histiocytosis: a case report. Front Immunol. 2024;15:1383255.","journal-title":"Front Immunol"},{"key":"830_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","volume":"26","author":"C Huang","year":"2023","unstructured":"Huang C, Chen B, Wang X, Xu J, Sun L, Wang D, et al. Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression. Gastric Cancer. 2023;26:691\u2013707.","journal-title":"Gastric Cancer"},{"key":"830_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0988-9","volume":"9","author":"L Sun","year":"2018","unstructured":"Sun L, Wang Q, Chen B, Zhao Y, Shen B, Wang H, et al. Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3\/mTOR-c-Myc signal axis. Cell Death Dis. 2018;9:928.","journal-title":"Cell Death Dis"},{"key":"830_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.884373","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Huang C, Ding Y, Wen S, Wang X, Guo S, et al. Inhibition of CCCTC binding factor-programmed cell death ligand 1 axis suppresses emergence of chemoresistance induced by gastric cancer-derived mesenchymal stem cells. Front Immunol. 2022;13:884373.","journal-title":"Front Immunol"},{"key":"830_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molimm.2025.01.005","volume":"178","author":"W Ji","year":"2025","unstructured":"Ji W, Xu J, Huang C, Liu T, Chen S, Zhao Y, et al. Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K\/AKT pathway. Mol Immunol. 2025;178:97\u2013106.","journal-title":"Mol Immunol"},{"key":"830_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04028-3","volume":"21","author":"W Hu","year":"2023","unstructured":"Hu W, Wang W, Jiang X, Wang Z, Lin R. Mesenchymal stem cells can prevent or promote the progression of colon cancer based on their timing of administration. J Transl Med. 2023;21:227.","journal-title":"J Transl Med"},{"key":"830_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41556-022-01024-5","volume":"24","author":"J Bae","year":"2022","unstructured":"Bae J, Liu L, Moore C, Hsu E, Zhang A, Ren Z, et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8(+) T cells to overcome immunotherapy resistance in cancer. Nat Cell Biol. 2022;24:1754\u201365.","journal-title":"Nat Cell Biol"},{"key":"830_CR28","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/cbin.11698","volume":"45","author":"F Heidari","year":"2021","unstructured":"Heidari F, Razmkhah M, Razban V, Erfani N. Effects of indoleamine 2, 3-dioxygenase (IDO) silencing on immunomodulatory function and cancer-promoting characteristic of adipose-derived mesenchymal stem cells (ASCs). Cell Biol Int. 2021;45:2544\u201356.","journal-title":"Cell Biol Int"},{"key":"830_CR29","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.7150\/thno.49717","volume":"10","author":"L Sun","year":"2020","unstructured":"Sun L, Huang C, Zhu M, Guo S, Gao Q, Wang Q, et al. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis. Theranostics. 2020;10:11950\u201362.","journal-title":"Theranostics"},{"key":"830_CR30","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/j.devcel.2025.07.014","volume":"60","author":"J Zheng","year":"2025","unstructured":"Zheng J, She H, Han R, Tang J, Dou Y, Lu C, et al. Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis. Dev Cell. 2025;60:3267-84.e7.","journal-title":"Dev Cell"},{"key":"830_CR31","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/cancers15112963","volume":"15","author":"F Blangero","year":"2023","unstructured":"Blangero F, Robert M, Andraud T, Dumontet C, Vidal H, Eljaafari A. Contribution of mesenchymal stem cells from obese adipose tissue to PD-L1 over-expression and breast cancer progression through pathogenic Th17 cell activation. Cancers (Basel). 2023;15:2963.","journal-title":"Cancers (Basel)"},{"key":"830_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113492","volume":"424","author":"Z Tao","year":"2023","unstructured":"Tao Z, Huang C, Wang D, Wang Q, Gao Q, Zhang H, et al. Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation. Exp Cell Res. 2023;424:113492.","journal-title":"Exp Cell Res"},{"key":"830_CR33","doi-asserted-by":"publisher","first-page":"6294717","DOI":"10.1155\/2017\/6294717","volume":"2017","author":"M Gazdic","year":"2017","unstructured":"Gazdic M, Simovic Markovic B, Jovicic N, Misirkic-Marjanovic M, Djonov V, Jakovljevic V, et al. Mesenchymal stem cells promote metastasis of lung cancer cells by downregulating systemic antitumor immune response. Stem Cells Int. 2017;2017:6294717.","journal-title":"Stem Cells Int"},{"key":"830_CR34","doi-asserted-by":"publisher","first-page":"1280601","DOI":"10.3389\/fimmu.2023.1280601","volume":"14","author":"A Hazrati","year":"2023","unstructured":"Hazrati A, Malekpour K, Mirsanei Z, Khosrojerdi A, Rahmani-Kukia N, Heidari N, et al. Cancer-associated mesenchymal stem\/stromal cells: role in progression and potential targets for therapeutic approaches. Front Immunol. 2023;14:1280601.","journal-title":"Front Immunol"},{"key":"830_CR35","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.3390\/ijms24043559","volume":"24","author":"Z Ma","year":"2023","unstructured":"Ma Z, Hua J, Liu J, Zhang B, Wang W, Yu X, et al. Mesenchymal stromal cell-based targeted therapy pancreatic cancer: progress and challenges. Int J Mol Sci. 2023;24:3559.","journal-title":"Int J Mol Sci"},{"key":"830_CR36","doi-asserted-by":"publisher","first-page":"1421854","DOI":"10.3389\/fimmu.2024.1421854","volume":"15","author":"R Mei","year":"2024","unstructured":"Mei R, Wan Z, Yang C, Shen X, Wang R, Zhang H, et al. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024;15:1421854.","journal-title":"Front Immunol"},{"key":"830_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110639","volume":"106","author":"Q Wang","year":"2023","unstructured":"Wang Q, Huang C, Wang D, Tao Z, Zhang H, Zhao Y, et al. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1\/Rad51 in gastric cancer. Cell Signal. 2023;106:110639.","journal-title":"Cell Signal"},{"key":"830_CR38","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","volume":"184","author":"SA Patel","year":"2010","unstructured":"Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010;184:5885\u201394.","journal-title":"J Immunol"},{"key":"830_CR39","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1089\/scd.2013.0166","volume":"22","author":"R Lin","year":"2013","unstructured":"Lin R, Ma H, Ding Z, Shi W, Qian W, Song J, et al. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer. Stem Cells Dev. 2013;22:2836\u201348.","journal-title":"Stem Cells Dev"},{"key":"830_CR40","first-page":"6265","volume":"15","author":"X Liu","year":"2018","unstructured":"Liu X, Hu J, Li Y, Cao W, Wang Y, Ma Z, et al. Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model. Oncol Lett. 2018;15:6265\u201374.","journal-title":"Oncol Lett"},{"key":"830_CR41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/cells9040873","volume":"9","author":"AA Hombach","year":"2020","unstructured":"Hombach AA, Geumann U, G\u00fcnther C, Hermann FG, Abken H. IL7-IL12 Engineered mesenchymal stem cells (MSCs) improve a CAR T cell attack against colorectal cancer cells. Cells. 2020;9:873.","journal-title":"Cells"},{"key":"830_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.3025","volume":"36","author":"Z Salmasi","year":"2020","unstructured":"Salmasi Z, Hashemi M, Mahdipour E, Nourani H, Abnous K, Ramezani M. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo. Biotechnol Prog. 2020;36:e3025.","journal-title":"Biotechnol Prog"},{"key":"830_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1689103","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang Y, Yin W, Lei Q, Fu Y, Liang Y, et al. Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. Front Immunol. 2025;16:1689103.","journal-title":"Front Immunol"},{"key":"830_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.omto.2022.01.007","volume":"24","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu C, Wang T, Kong F, Zhang H, Yi J, et al. Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model. Mol Ther Oncolytics. 2022;24:486\u201396.","journal-title":"Mol Ther Oncolytics"},{"key":"830_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.31557\/APJCP.2020.21.3.837","volume":"21","author":"F Peymaeei","year":"2020","unstructured":"Peymaeei F, Sadeghi F, Safari E, Khorrami S, Falahati M, Roudbar Mohammadi S, et al. Candida albicans beta-glucan induce anti- cancer activity of mesenchymal stem cells against lung cancer cell line: an In-Vitro experimental study. Asian Pac J Cancer Prev. 2020;21:837\u201343.","journal-title":"Asian Pac J Cancer Prev"},{"key":"830_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12916-025-04390-7","volume":"23","author":"J Yu","year":"2025","unstructured":"Yu J, Liu X, Jin L, Li H, Wang S, Yang Y, et al. Extracellular vesicles derived from menstrual blood-derived mesenchymal stem cells suppress inflammatory atherosclerosis by inhibiting NF-\u03baB signaling. BMC Med. 2025;23:565.","journal-title":"BMC Med"},{"key":"830_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13287-023-03245-3","volume":"14","author":"GRL Al-Awsi","year":"2023","unstructured":"Al-Awsi GRL, Alsaikhan F, Margiana R, Ahmad I, Patra I, Najm MAA, et al. Shining the light on mesenchymal stem cell-derived exosomes in breast cancer. Stem Cell Res Ther. 2023;14:21.","journal-title":"Stem Cell Res Ther"},{"key":"830_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/1389450122666210824142247","volume":"23","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb S, Fathi E, Mamandi A, Farahzadi R, Heidari HR. Mesenchymal stem cells and cancer stem cells: an overview of tumor- mesenchymal stem cell interaction for therapeutic interventions. Curr Drug Targets. 2022;23:60\u201371.","journal-title":"Curr Drug Targets"},{"key":"830_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084256","volume":"8","author":"JK Lee","year":"2013","unstructured":"Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS ONE. 2013;8:e84256.","journal-title":"PLoS ONE"},{"key":"830_CR50","first-page":"141","volume":"10","author":"DS Chulpanova","year":"2021","unstructured":"Chulpanova DS, Gilazieva ZE, Kletukhina SK, Aimaletdinov AM, Garanina EE, James V, et al. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing IL2 are able to stimulate CD8+ T-killers to kill human triple negative breast cancer cells. Biology (Basel). 2021;10:141.","journal-title":"Biology (Basel)"},{"key":"830_CR51","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/biom14070734","volume":"14","author":"JI Gil-Chinchilla","year":"2024","unstructured":"Gil-Chinchilla JI, Zapata AG, Moraleda JM, Garc\u00eda-Bernal D. Bioengineered mesenchymal stem\/stromal cells in anti-cancer therapy: current trends and future prospects. Biomolecules. 2024;14:734.","journal-title":"Biomolecules"},{"key":"830_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.7150\/ijbs.88500","volume":"20","author":"C Shan","year":"2024","unstructured":"Shan C, Liang Y, Wang K, Li P. Mesenchymal stem cell-derived extracellular vesicles in cancer therapy resistance: from biology to clinical opportunity. Int J Biol Sci. 2024;20:347\u201366.","journal-title":"Int J Biol Sci"},{"key":"830_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801589","volume":"8","author":"Y Lupu-Haber","year":"2019","unstructured":"Lupu-Haber Y, Bronshtein T, Shalom-Luxenburg H, D\u2019Atri D, Oieni J, Kaneti L, et al. Pretreating mesenchymal stem cells with cancer conditioned-media or proinflammatory cytokines changes the tumor and immune targeting by nanoghosts derived from these cells. Adv Healthc Mater. 2019;8:e1801589.","journal-title":"Adv Healthc Mater"},{"key":"830_CR54","doi-asserted-by":"publisher","first-page":"22968","DOI":"10.1021\/acsnano.5c02492","volume":"19","author":"J Zeng","year":"2025","unstructured":"Zeng J, Zhang Y, Gao Y, Jia M, Guo Y, Li X, et al. Biomimetic ginsenoside Rb1 and probucol co-assembled nanoparticles for targeted atherosclerosis therapy via inhibition of oxidative stress, inflammation, and lipid deposition. ACS Nano. 2025;19:22968\u201387.","journal-title":"ACS Nano"},{"key":"830_CR55","first-page":"23","volume":"22","author":"A Hassanzadeh","year":"2022","unstructured":"Hassanzadeh A, Shamlou S, Yousefi N, Nikoo M, Verdi J. Genetically-modified stem cell in regenerative medicine and cancer therapy; a new era. Curr Gene Ther. 2022;22:23\u201339.","journal-title":"Curr Gene Ther"},{"key":"830_CR56","first-page":"322","volume":"38","author":"H Ye","year":"2023","unstructured":"Ye H, Pan J, Gong E, Cai X, Xu C, Li Y, et al. Inhibitory effect of immunologically activated mesenchymal stem cells on lung cancer cell growth and metastasis. Cancer Biother Radiopharm. 2023;38:322\u201335.","journal-title":"Cancer Biother Radiopharm"},{"key":"830_CR57","doi-asserted-by":"publisher","first-page":"BSR20204356","DOI":"10.1042\/BSR20204356","volume":"41","author":"AF Alkhuriji","year":"2021","unstructured":"Alkhuriji AF, Alsaiari SG, Alomar SY, Alnafjan AA, Alobaid H, El-Khadragy MF. Effect of mesenchymal stem cells on cytochrome-c release and inflammation in colon cancer induced by 1,2-dimethylhydrazine in Wistar albino rats. Biosci Rep. 2021;41:BSR20204356.","journal-title":"Biosci Rep"},{"key":"830_CR58","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.3390\/ijms25126746","volume":"25","author":"KH Wang","year":"2024","unstructured":"Wang KH, Chang YH, Ding DC. Bone marrow mesenchymal stem cells promote ovarian cancer cell proliferation via cytokine interactions. Int J Mol Sci. 2024;25:6746.","journal-title":"Int J Mol Sci"},{"key":"830_CR59","first-page":"2439","volume":"13","author":"MG Kim","year":"2023","unstructured":"Kim MG, Lee YJ, Jung JH, Chang DY, Bashyal N, Suh-Kim H, et al. Enhanced antitumor efficacy of mesenchymal stem cells expressing cytosine deaminase and 5-fluorocytosine combined with \u03b1-galactosylceramide in a colon cancer model. Am J Cancer Res. 2023;13:2439\u201351.","journal-title":"Am J Cancer Res"},{"key":"830_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114644","volume":"190","author":"A Babaei","year":"2021","unstructured":"Babaei A, Soleimanjahi H, Soleimani M, Arefian E. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer. Biochem Pharmacol. 2021;190:114644.","journal-title":"Biochem Pharmacol"},{"key":"830_CR61","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/jcp.30135","volume":"236","author":"H Aboulkheyr Es","year":"2021","unstructured":"Aboulkheyr Es H, Bigdeli B, Zhand S, Aref AR, Thiery JP, Warkiani ME. Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells. J Cell Physiol. 2021;236:3918\u201328.","journal-title":"J Cell Physiol"},{"key":"830_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101664","volume":"73","author":"DS Chulpanova","year":"2021","unstructured":"Chulpanova DS, Gilazieva ZE, Akhmetzyanova ER, Kletukhina SK, Rizvanov AA, Solovyeva VV. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-\u03b21 can kill carcinoma cancer cells. Tissue Cell. 2021;73:101664.","journal-title":"Tissue Cell"},{"key":"830_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/scd.2018.0125","volume":"28","author":"Y Shen","year":"2019","unstructured":"Shen Y, Xue C, Li X, Ba L, Gu J, Sun Z, et al. Effects of gastric cancer cell-derived exosomes on the immune regulation of mesenchymal stem cells by the NF-kB signaling pathway. Stem Cells Dev. 2019;28:464\u201376.","journal-title":"Stem Cells Dev"},{"key":"830_CR64","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232347036250610065753","author":"F Aminian","year":"2025","unstructured":"Aminian F, Babaei N, Ghaleh HEG, Khamisipour G, Farzanehpour M. Therapeutic effects of mesenchymal stem cells carrying echovirus in mouse models of breast cancer. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232347036250610065753","journal-title":"Curr Gene Ther"},{"key":"830_CR65","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ncb2690","volume":"15","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol. 2013;15:284\u201394.","journal-title":"Nat Cell Biol"},{"key":"830_CR66","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.3390\/ijms26136178","volume":"26","author":"NA Ababneh","year":"2025","unstructured":"Ababneh NA, AlDiqs R, Nashwan S, Ismail MA, Barham R, Alatoom RM, et al. Exosomes derived from induced and Wharton\u2019s jelly-derived mesenchymal stem cells promote senescence-like features and migration in cancer cells. Int J Mol Sci. 2025;26:6178.","journal-title":"Int J Mol Sci"},{"key":"830_CR67","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/mt.2011.152","volume":"19","author":"HJ Wei","year":"2011","unstructured":"Wei HJ, Wu AT, Hsu CH, Lin YP, Cheng WF, Su CH, et al. The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine. Mol Ther. 2011;19:2249\u201357.","journal-title":"Mol Ther"},{"key":"830_CR68","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2174\/0115680096273465231201115839","volume":"24","author":"R Karbalaee","year":"2024","unstructured":"Karbalaee R, Mehdizadeh S, Ghaleh HEG, Izadi M, Kondori BJ, Dorostkar R, et al. The effects of mesenchymal stem cells loaded with oncolytic coxsackievirus A21 on mouse models of colorectal cancer. Curr Cancer Drug Targets. 2024;24:967\u201374.","journal-title":"Curr Cancer Drug Targets"},{"key":"830_CR69","doi-asserted-by":"publisher","first-page":"21229","DOI":"10.1038\/s41598-021-00754-0","volume":"11","author":"C Vogeley","year":"2021","unstructured":"Vogeley C, Degistirici \u00d6, Twarock S, Wladarz J, Reiners O, Gorges T, et al. The regulatory effect of hyaluronan on human mesenchymal stem cells\u2019 fate modulates their interaction with cancer cells in vitro. Sci Rep. 2021;11:21229.","journal-title":"Sci Rep"},{"key":"830_CR70","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3892\/mmr.2012.1019","volume":"6","author":"J Cheng","year":"2012","unstructured":"Cheng J, Li L, Liu Y, Wang Z, Zhu X, Bai X. Interleukin-1\u03b1 induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells. Mol Med Rep. 2012;6:955\u201360.","journal-title":"Mol Med Rep"},{"key":"830_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1479-5876-11-20","volume":"11","author":"EK Mader","year":"2013","unstructured":"Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, et al. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med. 2013;11:20.","journal-title":"J Transl Med"},{"key":"830_CR72","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1007\/s12010-023-04757-7","volume":"196","author":"M Yuce","year":"2024","unstructured":"Yuce M, Albayrak E. Paracrine factors released from tonsil-derived mesenchymal stem cells inhibit proliferation of hematological cancer cells under hyperthermia in co-culture model. Appl Biochem Biotechnol. 2024;196:4105\u201324.","journal-title":"Appl Biochem Biotechnol"},{"key":"830_CR73","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.3390\/ijms26136223","volume":"26","author":"AR Rakhmatullina","year":"2025","unstructured":"Rakhmatullina AR, Zolotykh MA, Filina YV, Sagdeeva AR, Rozhina EV, Gabdoulkhakova AG, et al. In Vitro Analysis of PMEPA1 upregulation in mesenchymal stem cells induced by prostate cancer cells. Int J Mol Sci. 2025;26:6223.","journal-title":"Int J Mol Sci"},{"key":"830_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12399","volume":"51","author":"R Xu","year":"2018","unstructured":"Xu R, Zhao X, Zhao Y, Chen B, Sun L, Xu C, et al. Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4+ T cells. Cell Prolif. 2018;51:e12399.","journal-title":"Cell Prolif"},{"key":"830_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yexcr.2017.09.036","volume":"361","author":"M Wang","year":"2017","unstructured":"Wang M, Chen B, Sun XX, Zhao XD, Zhao YY, Sun L, et al. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg\/Th17 balance to promote gastric cancer progression. Exp Cell Res. 2017;361:19\u201329.","journal-title":"Exp Cell Res"},{"key":"830_CR76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biocel.2019.02.001","volume":"110","author":"S Mandal","year":"2019","unstructured":"Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs. Int J Biochem Cell Biol. 2019;110:59\u201369.","journal-title":"Int J Biochem Cell Biol"},{"key":"830_CR77","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jss.2014.02.047","volume":"190","author":"H Kikuchi","year":"2014","unstructured":"Kikuchi H, Yagi H, Hasegawa H, Ishii Y, Okabayashi K, Tsuruta M, et al. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. J Surg Res. 2014;190:134\u201343.","journal-title":"J Surg Res"},{"key":"830_CR78","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/biom14111351","volume":"14","author":"A Dairov","year":"2024","unstructured":"Dairov A, Sekenova A, Alimbek S, Nurkina A, Shakhatbayev M, Kumasheva V, et al. Psoriasis: the versatility of mesenchymal stem cell and exosome therapies. Biomolecules. 2024;14:1351.","journal-title":"Biomolecules"},{"key":"830_CR79","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cells13151270","volume":"13","author":"K Starska-Kowarska","year":"2024","unstructured":"Starska-Kowarska K. Role of mesenchymal stem\/stromal cells in head and neck cancer-regulatory mechanisms of tumorigenic and immune activity, chemotherapy resistance, and therapeutic benefits of stromal cell-based pharmacological strategies. Cells. 2024;13:1270.","journal-title":"Cells"},{"key":"830_CR80","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","volume":"16","author":"F Baron","year":"2010","unstructured":"Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, et al. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant. 2010;16:838\u201347.","journal-title":"Biol Blood Marrow Transplant"},{"key":"830_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101751","volume":"5","author":"K Liu","year":"2024","unstructured":"Liu K, Kong L, Cui H, Zhang L, Xin Q, Zhuang Y, et al. Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Rep Med. 2024;5:101751.","journal-title":"Cell Rep Med"},{"key":"830_CR82","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ymthe.2020.01.019","volume":"28","author":"D Ruano","year":"2020","unstructured":"Ruano D, L\u00f3pez-Mart\u00edn JA, Moreno L, Lassaletta \u00c1, Bautista F, Andi\u00f3n M, et al. First-in-human, first-in-child trial of autologous MSCs carrying the oncolytic virus Icovir-5 in patients with advanced tumors. Mol Ther. 2020;28:1033\u201342.","journal-title":"Mol Ther"},{"key":"830_CR83","doi-asserted-by":"publisher","first-page":"e001703","DOI":"10.1136\/jitc-2020-001703","volume":"9","author":"A Morales-Molina","year":"2021","unstructured":"Morales-Molina A, Gambera S, Leo A, Garc\u00eda-Castro J. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma. J Immunother Cancer. 2021;9:e001703.","journal-title":"J Immunother Cancer"},{"key":"830_CR84","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/neurintsurg-2021-018190","volume":"14","author":"SR Chen","year":"2022","unstructured":"Chen SR, Chen MM, Ene C, Lang FF, Kan P. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors. J Neurointerv Surg. 2022;14:533\u20138.","journal-title":"J Neurointerv Surg"},{"key":"830_CR85","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s13063-023-07594-5","volume":"24","author":"KK Jakobsen","year":"2023","unstructured":"Jakobsen KK, Carlander AF, Gr\u00f8nh\u00f8j C, Todsen T, Melchiors J, Paaske N, et al. Effectiveness and safety of mesenchymal stem\/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study. Trials. 2023;24:567.","journal-title":"Trials"},{"key":"830_CR86","doi-asserted-by":"publisher","first-page":"793","DOI":"10.18632\/oncotarget.28672","volume":"15","author":"T Minev","year":"2024","unstructured":"Minev T, Balbuena S, Gill JM, Marincola FM, Kesari S, Lin F. Mesenchymal stem cells - the secret agents of cancer immunotherapy: promises, challenges, and surprising twists. Oncotarget. 2024;15:793\u2013805.","journal-title":"Oncotarget"},{"key":"830_CR87","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/bph.70032","volume":"182","author":"L Lin","year":"2025","unstructured":"Lin L, Sun B, Hu Y, Yang W, Li J, Wang D, et al. Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. Br J Pharmacol. 2025;182:3476\u2013502.","journal-title":"Br J Pharmacol"},{"key":"830_CR88","doi-asserted-by":"crossref","first-page":"43196","DOI":"10.26717\/BJSTR.2023.51.008178","volume":"51","author":"TT Van Thuy","year":"2023","unstructured":"Van Thuy TT. Clinical application of mesenchymal stem cells for cancer therapy-a review of registered clinical trials. Biomed J Scient Tech Res. 2023;51:43196\u2013221.","journal-title":"Biomed J Scient Tech Res"},{"key":"830_CR89","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13770-018-0128-8","volume":"15","author":"SW Han","year":"2018","unstructured":"Han SW, Kim YY, Kang WJ, Kim HC, Ku SY, Kang BC, et al. The use of normal stem cells and cancer stem cells for potential anti-cancer therapeutic strategy. Tissue Eng Regen Med. 2018;15:365\u201380.","journal-title":"Tissue Eng Regen Med"},{"key":"830_CR90","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms23062927","volume":"23","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhai Y, Wu L, Wang Y, Wu P, Xiong L. Mesenchymal stem cell-derived extracellular vesicles: pleiotropic impacts on breast cancer occurrence, development, and therapy. Int J Mol Sci. 2022;23:2927.","journal-title":"Int J Mol Sci"},{"key":"830_CR91","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"830_CR92","doi-asserted-by":"crossref","unstructured":"Mei R, Wan Z, Yang C, Shen X, Wang R, Zhang H, et al. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024;15:1421854.","DOI":"10.3389\/fimmu.2024.1421854"},{"key":"830_CR93","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641\u20138.","journal-title":"Cytotherapy"},{"key":"830_CR94","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res. 2014;74:1576\u201387.","journal-title":"Cancer Res"},{"key":"830_CR95","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/clo.2005.7.154","volume":"7","author":"S Colleoni","year":"2005","unstructured":"Colleoni S, Donofrio G, Lagutina I, Duchi R, Galli C, Lazzari G. Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells. Cloning Stem Cells. 2005;7:154\u201366.","journal-title":"Cloning Stem Cells"},{"key":"830_CR96","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/cells9020504","volume":"9","author":"P Mueller","year":"2020","unstructured":"Mueller P, Wolfien M, Ekat K, Lang CI, Koczan D, Wolkenhauer O, et al. RNA-Based strategies for cardiac reprogramming of human mesenchymal stromal cells. Cells. 2020;9:504.","journal-title":"Cells"},{"key":"830_CR97","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1158\/1078-0432.CCR-24-3835","volume":"31","author":"TA van Schaik","year":"2025","unstructured":"van Schaik TA, Chen KS, Kanaya N, Moreno-Lama L, Freeman NW, Wang M, et al. Antitumor immunity mediated by engineered stem cells exploiting TRAIL-induced cell death and FLT3L immunomodulation. Clin Cancer Res. 2025;31:2793\u2013813.","journal-title":"Clin Cancer Res"},{"key":"830_CR98","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.bbrc.2017.12.007","volume":"495","author":"X Tan","year":"2018","unstructured":"Tan X, Dai Q, Guo T, Xu J, Dai Q. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes. Biochem Biophys Res Commun. 2018;495:2490\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"830_CR99","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/stcltm\/szab007","volume":"11","author":"PA Romec\u00edn","year":"2022","unstructured":"Romec\u00edn PA, Vinyoles M, L\u00f3pez-Mill\u00e1n B, de la Guardia RD, Atucha NM, Querol S, et al. Robust In Vitro and In Vivo immunosuppressive and anti-inflammatory properties of inducible caspase-9-mediated apoptotic mesenchymal stromal\/stem cell. Stem Cells Transl Med. 2022;11:88\u201396.","journal-title":"Stem Cells Transl Med"},{"key":"830_CR100","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1042\/bst20180079","volume":"46","author":"WS Toh","year":"2018","unstructured":"Toh WS, Lai RC, Zhang B, Lim SK. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018;46:843\u201353.","journal-title":"Biochem Soc Trans"},{"key":"830_CR101","doi-asserted-by":"publisher","first-page":"1282860","DOI":"10.3389\/fcell.2023.1282860","volume":"11","author":"T Tertel","year":"2023","unstructured":"Tertel T, Dittrich R, Ars\u00e8ne P, Jensen A, Giebel B. EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro. Front Cell Dev Biol. 2023;11:1282860.","journal-title":"Front Cell Dev Biol"},{"key":"830_CR102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1479-5876-9-47","volume":"9","author":"TS Chen","year":"2011","unstructured":"Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011;9:47.","journal-title":"J Transl Med"},{"key":"830_CR103","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.3390\/ijms25137133","volume":"25","author":"B Dai","year":"2024","unstructured":"Dai B, Clark AM, Wells A. Mesenchymal stem cell-secreted exosomes and soluble signals regulate breast cancer metastatic dormancy: current progress and future outlook. Int J Mol Sci. 2024;25:7133.","journal-title":"Int J Mol Sci"},{"key":"830_CR104","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan T, Luo M, Wei X. Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol. 2021;14:195.","journal-title":"J Hematol Oncol"},{"key":"830_CR105","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","volume":"43","author":"R Antoon","year":"2024","unstructured":"Antoon R, Overdevest N, Saleh AH, Keating A. Mesenchymal stromal cells as cancer promoters. Oncogene. 2024;43:3545\u201355.","journal-title":"Oncogene"},{"key":"830_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2025.101058","volume":"31","author":"Y Shimizu","year":"2026","unstructured":"Shimizu Y, Inoue Y, Matsuura N, Ishii T, Sowa Y, Sunami H, et al. Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation. Regen Ther. 2026;31:101058.","journal-title":"Regen Ther"},{"key":"830_CR107","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/stem.433","volume":"28","author":"CA Ramos","year":"2010","unstructured":"Ramos CA, Asgari Z, Liu E, Yvon E, Heslop HE, Rooney CM, et al. An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells. 2010;28:1107\u201315.","journal-title":"Stem Cells"},{"key":"830_CR108","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","volume":"16","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang J, Li Y, Feng C, Shao C, Shi Y, et al. Engineered mesenchymal stem\/stromal cells against cancer. Cell Death Dis. 2025;16:113.","journal-title":"Cell Death Dis"},{"key":"830_CR109","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","volume":"57","author":"K Lv","year":"2025","unstructured":"Lv K, Zhang Y, Yin G, Li X, Zhong M, Zhu X, et al. Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation. Exp Mol Med. 2025;57:1202\u201315.","journal-title":"Exp Mol Med"},{"key":"830_CR110","doi-asserted-by":"crossref","unstructured":"Azad T, Hong K, Wu F, Mao J, Zhou X, Xie H, et al. Donor age and sex program MSC secretome signaling: a quadrant framework for precision therapy. Stem Cell Res Ther. 2026;17:169.","DOI":"10.1186\/s13287-026-04976-9"},{"key":"830_CR111","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcyt.2024.10.008","volume":"27","author":"L Renesme","year":"2025","unstructured":"Renesme L, Cobey KD, Lalu MM, Bubela T, Chinnadurai R, De Vos J, et al. Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics. Cytotherapy. 2025;27:146\u201368.","journal-title":"Cytotherapy"},{"key":"830_CR112","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","volume":"22","author":"R Chinnadurai","year":"2018","unstructured":"Chinnadurai R, Rajan D, Qayed M, Arafat D, Garcia M, Liu Y, et al. Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach. Cell Rep. 2018;22:2504\u201317.","journal-title":"Cell Rep"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00830-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-026-00830-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00830-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:03:30Z","timestamp":1790643810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-026-00830-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s13770-026-00830-4","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no animal experiments carried out for this article.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}